Cargando…
Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine
BACKGROUND: Ezogabine (also known by the international nonproprietary name of retigabine) is an antiepileptic drug codeveloped and comarketed by Valeant Pharmaceuticals North America and GlaxoSmithKline, which reduces neuronal excitability by enhancing the activity of potassium channels and has the...
Autores principales: | Brickel, Neil, DeRossett, Sarah, Buraglio, Mauro, Evans, Christopher, Jones, Siôn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650885/ https://www.ncbi.nlm.nih.gov/pubmed/23671389 http://dx.doi.org/10.2147/TCRM.S42536 |
Ejemplares similares
-
Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study
por: Tompson, Debra J, et al.
Publicado: (2014) -
Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey
por: Ishihara, Lianna, et al.
Publicado: (2015) -
Discolored Ureteral Stents: Findings in Urinalysis and Urine Culture
por: Kawahara, Takashi, et al.
Publicado: (2015) -
The comparison of automated urine analyzers with manual microscopic examination for urinalysis automated urine analyzers and manual urinalysis
por: İnce, Fatma Demet, et al.
Publicado: (2016) -
Ezogabine skin discoloration is reversible after discontinuation
por: Mathias, Sally V., et al.
Publicado: (2017)